WANBURY (WANBURY) Share Price Rises 8.80% as Stock Trades at Rs 205.95

WANBURY Share Price is trading higher today at Rs 205.95, up 8.80% from the previous close of Rs 189.3, with market capitalisation at Rs 695.84 Cr. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the move relevant for investors tracking WANBURY Share Price Today, especially because the stock is also showing a clear gap between its current price and the prior close, while the broader context now shifts to valuation and sector comparison. In Univest terms, this is a straightforward share price rise backed by measurable price action rather than a stated trigger. The next things to monitor are whether WANBURY Share Price can hold near the day high and how its fundamentals compare with the Healthcare peer set.

WANBURY Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 205.95
Previous Close	Rs 189.3
Today's Move	Rs 16.65 (+8.8%)
Open	Rs 195.9
High	Rs 205.95
Low	Rs 191.3
Market Capitalisation	Rs 695.84 crore
Market Cap Category	Micro Cap

Wanbury Ltd. (WANBURY) rose to Rs 205.95 from the previous close of Rs 189.3, a move of Rs 16.65 or 8.8%. The stock opened at Rs 195.9, reached a high of Rs 205.95, recorded a low of Rs 191.3.

WANBURY Share Price is higher by Rs 16.65 today, and the stock is last traded at Rs 205.95 after opening at Rs 195.9. The move lifted WANBURY Share Price to the day high of Rs 205.95, while the day low was Rs 191.3. This means the stock moved through a Rs 14.65 intraday range during the trading window. For readers following WANBURY Share Price Today, the immediate take-away is simple: the stock has advanced from the previous close and is trading near the top of the day’s range. That is the factual picture behind today’s share price gain, and it is the first layer of WANBURY Share Price news on Univest. The next layer is valuation and balance-sheet context, which helps explain how this price rise fits the company’s profile.

Wanbury Ltd. (WANBURY) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 695.84 crore
P/E Ratio	11.84x
P/B Ratio	4.51x
ROE	67.87%
ROCE	30.31%
EPS	Rs 15.98
Book Value Per Share	Rs 41.96
Dividend Yield	0%

Wanbury Ltd. (WANBURY) fundamental metrics show P/E 11.84x, P/B 4.51x, ROE 67.87%, ROCE 30.31%. Taken on their own, these numbers offer context rather than a trading signal.

Wanbury Ltd. has a market capitalisation of Rs 695.84 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 11.84x, P/B at 4.51x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 67.87% and ROCE of 30.31%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 15.98, book value per share of Rs 41.96, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.79x, median ROE of 11.73%, median ROCE of 13.63%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	11.84x
Benchmark Median P/E	31.79x
Benchmark Average P/E	47.98x
Benchmark P/E Range	3.58x to 668.09x
Company P/B Ratio	4.51x
Benchmark Median P/B	2.9x
Company ROE	67.87%
Benchmark Median ROE	11.73%
Company ROCE	30.31%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 695.84 crore
Benchmark Median Market Cap	Rs 812.84 crore

Wanbury Ltd. (WANBURY) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Wanbury Ltd. (WANBURY) has a P/E ratio of 11.84x, which is below the benchmark median of 31.79x, a difference of -62.76%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Wanbury Ltd. (WANBURY) has a ROE of 67.87%, which is above the benchmark median of 11.73%, a difference of +478.6%. Wanbury Ltd. (WANBURY) has a ROCE of 30.31%, which is above the benchmark median of 13.63%, a difference of +122.38%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries Ltd.	SUNPHARMA	4,34,279.63	35.35	4.94	14.85	19.11
Divi's Laboratories Ltd.	DIVISLAB	2,46,737.12	83.61	13.85	16.19	21.51
Torrent Pharmaceuticals Ltd.	TORNTPHARM	1,81,129.27	82.93	20.15	26.76	19.27
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,14,239.13	25.16	4.21	19.69	21.39
Cipla Ltd.	CIPLA	1,08,808.05	31.97	3.07	11.83	16

Wanbury Ltd. (WANBURY) has a P/E ratio of 11.84x compared with the displayed peer median of 35.35x. The comparison is relative and should not be read as a recommendation. Its ROE of 67.87% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 30.31% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wanbury Ltd. (WANBURY) has a market capitalisation of Rs 695.84 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching WANBURY

• WANBURY Share Price is up 8.80% today and is trading near the day high, which keeps the price action in focus on Univest.
• WANBURY Share Price is being read alongside a P/E of 11.84 and P/B of 4.51, giving the move a clear valuation context.
• WANBURY Share Price shows ROE of 67.87% and ROCE of 30.31%, both well above the same-industry benchmark medians.
• WANBURY Share Price is below the industry median market cap, so the move is being tracked with sector comparison in mind.
• WANBURY Share Price remains relevant because no company-specific catalyst has been established, making the verified price data the main story today.

About WANBURY

WANBURY is part of the Healthcare sector and operates in the Pharmaceuticals & Drugs industry. The company’s listing context on Univest is shaped by its share price, market capitalisation and valuation ratios rather than by any single stated event driver today. WANBURY Share Price therefore matters not just as a daily move, but also as a reference point for understanding how the business is being valued relative to its operating profile. The company’s revenue mix and segment detail are not part of the current market snapshot, so the clearest visible story is the one told by its valuation and return metrics. WANBURY Share Price today sits alongside EPS of 15.98, book value of Rs 41.96 and ROE of 67.87%, all of which help readers place the company within the Pharmaceuticals & Drugs industry on Univest.

Frequently Asked Questions

Why is WANBURY Share Price rising today?

Ans. WANBURY Share Price is higher by 8.80% today, but according to latest Univest data, the price event is confirmed and no company-specific catalyst is established. The move is visible through the open, high, low and previous close.

What is the current WANBURY Share Price?

Ans. WANBURY Share Price is trading at Rs 205.95. It is up from the previous close of Rs 189.3 and has moved to the day high of Rs 205.95, keeping the intraday price action in focus.

How much did WANBURY Share Price gain today?

Ans. WANBURY Share Price gained Rs 16.65, which translates into an 8.80% rise from the previous close. That is the day’s visible move, and it is the main reason the stock is appearing in stock news screens today.

What is the market cap of WANBURY?

Ans. WANBURY has a market capitalisation of Rs 695.84 Cr. In the same-industry benchmark set, that sits below the median market cap of Rs 812.84 Cr, while remaining within the wider Pharmaceuticals & Drugs comparison range.

Is WANBURY Share Price expensive or low-valued on valuation?

Ans. WANBURY Share Price has a P/E of 11.84, which is below the industry median and average. Its P/B of 4.51 is above the industry median but close to the benchmark average, so valuation looks mixed.

What do WANBURY’s ROE and ROCE indicate?

Ans. WANBURY reports ROE of 67.87% and ROCE of 30.31%. Both are above the same-industry medians, which gives WANBURY Share Price stronger return context than many peers in the Pharmaceuticals & Drugs industry.

How does WANBURY compare with peers?

Ans. WANBURY Share Price has a lower P/E than peers such as Sun Pharmaceutical, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its ROE is also higher than the listed peer figures in this comparison.

Should investors track WANBURY Share Price on Univest?

Ans. Investors tracking WANBURY Share Price can use Univest for live price updates, valuation ratios, EPS, book value, ROE, ROCE and 52-week levels. The platform keeps the stock’s price action and fundamentals in one view.

Track WANBURY Share Price on Univest

Use Wanbury Ltd. (WANBURY) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track WANBURY Share Price on Univest for live share price updates, market cap, P/E ratio, P/B ratio, EPS, book value, ROE, ROCE and 52-week levels. Univest also helps readers follow WANBURY Stock News, WANBURY Share Price Today and broader Healthcare sector context in one place.